The drug and biotech sector has recovered over the past couple of months, following a slow start to the year, primarily due ...

Kneat's SaaS model automates validation processes in pharma and biotech, reducing errors and ensuring compliance. Learn why ...

Q4 2024 revenue of $1.5 million in pharma services; full year revenue of $1.9 millionGraftAssure RUO assay launched July ...

Learn more about whether Elanco Animal Health Incorporated or Harmony Biosciences Holdings, Inc. is a better investment based ...

The end of an earnings season can be a great time to discover new stocks and assess how companies are handling the current ...

Spooked by US president's threat, several Indian pharma players lobby for blanket duty waiver on drugs coming from America, ...

Rocket has long been a predominately direct-to-consumer lender, but it also operates a "partner" network, closing home loans ...

Bankrupt drugmaker Purdue Pharma filed a new bankruptcy plan on Tuesday, a major step towards finalizing a proposed opioid ...

Analysts have set 12-month price targets for Eton Pharmaceuticals, revealing an average target of $24.4, a high estimate of $33.00, and a low estimate of $17.00. Marking an increase of 22.0%, the ...

Sun Pharmaceutical Industries Limited has announced the completion of its 100% acquisition of Antibe Therapeutics Inc., a ...

Drugmakers are urging the Trump administration and European Union officials to exclude medical goods from expanding tariff ...

Chromatography companies recognize significant opportunities in the biotech and pharma sectors, yet face uncertainty driven by rising tariffs and the growing integration of AI tools.